10-102627177-T-C

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_016169.4(SUFU):ā€‹c.1299T>Cā€‹(p.Ile433Ile) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.114 in 1,613,514 control chromosomes in the GnomAD database, including 15,918 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.15 ( 2263 hom., cov: 32)
Exomes š‘“: 0.11 ( 13655 hom. )

Consequence

SUFU
NM_016169.4 splice_region, synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.661
Variant links:
Genes affected
SUFU (HGNC:16466): (SUFU negative regulator of hedgehog signaling) The Hedgehog signaling pathway plays an important role in early human development. The pathway is a signaling cascade that plays a role in pattern formation and cellular proliferation during development. This gene encodes a negative regulator of the hedgehog signaling pathway. Defects in this gene are a cause of medulloblastoma. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 10-102627177-T-C is Benign according to our data. Variant chr10-102627177-T-C is described in ClinVar as [Benign]. Clinvar id is 260687.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-102627177-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.661 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SUFUNM_016169.4 linkuse as main transcriptc.1299T>C p.Ile433Ile splice_region_variant, synonymous_variant 11/12 ENST00000369902.8 NP_057253.2 Q9UMX1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SUFUENST00000369902.8 linkuse as main transcriptc.1299T>C p.Ile433Ile splice_region_variant, synonymous_variant 11/121 NM_016169.4 ENSP00000358918.4 Q9UMX1-1

Frequencies

GnomAD3 genomes
AF:
0.151
AC:
23040
AN:
152144
Hom.:
2255
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.219
Gnomad AMI
AF:
0.122
Gnomad AMR
AF:
0.193
Gnomad ASJ
AF:
0.0643
Gnomad EAS
AF:
0.416
Gnomad SAS
AF:
0.222
Gnomad FIN
AF:
0.0725
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0931
Gnomad OTH
AF:
0.163
GnomAD3 exomes
AF:
0.160
AC:
40291
AN:
251478
Hom.:
4675
AF XY:
0.155
AC XY:
21016
AN XY:
135908
show subpopulations
Gnomad AFR exome
AF:
0.224
Gnomad AMR exome
AF:
0.267
Gnomad ASJ exome
AF:
0.0715
Gnomad EAS exome
AF:
0.413
Gnomad SAS exome
AF:
0.225
Gnomad FIN exome
AF:
0.0745
Gnomad NFE exome
AF:
0.0863
Gnomad OTH exome
AF:
0.124
GnomAD4 exome
AF:
0.111
AC:
161590
AN:
1461254
Hom.:
13655
Cov.:
32
AF XY:
0.113
AC XY:
82193
AN XY:
726982
show subpopulations
Gnomad4 AFR exome
AF:
0.221
Gnomad4 AMR exome
AF:
0.261
Gnomad4 ASJ exome
AF:
0.0679
Gnomad4 EAS exome
AF:
0.447
Gnomad4 SAS exome
AF:
0.226
Gnomad4 FIN exome
AF:
0.0753
Gnomad4 NFE exome
AF:
0.0823
Gnomad4 OTH exome
AF:
0.123
GnomAD4 genome
AF:
0.152
AC:
23084
AN:
152260
Hom.:
2263
Cov.:
32
AF XY:
0.154
AC XY:
11484
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.219
Gnomad4 AMR
AF:
0.194
Gnomad4 ASJ
AF:
0.0643
Gnomad4 EAS
AF:
0.416
Gnomad4 SAS
AF:
0.222
Gnomad4 FIN
AF:
0.0725
Gnomad4 NFE
AF:
0.0931
Gnomad4 OTH
AF:
0.166
Alfa
AF:
0.108
Hom.:
2730
Bravo
AF:
0.166
Asia WGS
AF:
0.314
AC:
1086
AN:
3478
EpiCase
AF:
0.0887
EpiControl
AF:
0.0870

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 31, 2016Variant summary: The SUFU c.1299T>C (p.Ile433Ile) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may affect ESE site of SC35. However, these predictions have yet to be confirmed by functional studies. This variant was found in 19257/121358 control chromosomes (2233 homozygotes) at a frequency of 0.1586793, which is significantly higher than the estimated maximal expected allele frequency of a pathogenic SUFU variant (0.000001), suggesting this variant is likely a benign polymorphism. Taken together, this variant is classified as benign. -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Gorlin syndrome;C0025149:Medulloblastoma Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Familial meningioma Benign:1
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Medulloblastoma Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 09, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
12
DANN
Benign
0.63

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17114803; hg19: chr10-104386934; COSMIC: COSV64017293; API